Log in

Furosemide stress test to predict acute kidney injury progression in critically ill children

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Furosemide stress test (FST) is a novel functional biomarker for predicting severe acute kidney injury (AKI); however, pediatric studies are limited.

Methods

Children 3 months to 18 years of age admitted to the intensive care unit (ICU) of a tertiary care hospital from Nov 2019 to July 2021 were screened and those who developed AKI stage 1 or 2 within 7 days of admission underwent FST (intravenous furosemide 1 mg/kg). Urine output was measured hourly for the next 6 h; a value > 2 ml/kg within the first 2 h was deemed furosemide responsive. Other biomarkers like plasma neutrophil gelatinase-associated lipocalin (NGAL) and proenkephalin (PENK) were also evaluated.

Results

Of the 480 admitted patients, 51 developed AKI stage 1 or 2 within 7 days of admission and underwent FST. Nine of these patients were furosemide non-responsive. Thirteen (25.5%) patients (eight of nine from FST non-responsive group) developed stage 3 AKI within 7 days of FST, nine (17.6%) of whom (seven from non-responsive group) required kidney support therapy (KST). FST emerged as a good biomarker for predicting stage 3 AKI and need for KST with area-under-the-curve (AUC) being 0.93 ± 0.05 (95% CI 0.84–1.0) and 0.96 ± 0.03 (95% CI 0.9–1.0), respectively. FST outperformed NGAL and PENK in predicting AKI stage 3 and KST; however, the combination did not improve the diagnostic accuracy.

Conclusions

Furosemide stress test is a simple, inexpensive, and robust biomarker for predicting stage 3 AKI and KST need in critically ill children. Further research is required to identify the best FST cut-off in children.

Graphical abstract

A higher resolution version of the Graphical abstract is available as Supplementary information

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable. Data subsets are available with the corresponding author.

References

  1. Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, AWARE Investigators (2017) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376:11–20

    Article  PubMed  Google Scholar 

  2. Sutherland SM, Ji J, Sheikhi FH, Widen E, Tian L, Alexander SR, Ling XB (2013) AKI in hospitalized children. Clin J Am Soc Nephrol 8:1661–1669

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sanchez-Pinto LN, Goldstein SL, Schneider JB, Khemani RG (2015) Association between progression and improvement of acute kidney injury and mortality in critically ill children. Pediatr Crit Care Med 16:703–710

    Article  PubMed  Google Scholar 

  4. Alkandari O, Eddington KA, Hyder A, Gauvin F, Ducruet T, Gottesman R, Phan V, Zappitelli M (2011) Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care 15:R146

    Article  PubMed  PubMed Central  Google Scholar 

  5. Greenberg JH, Coca S, Parikh CR (2014) Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 15:184

    Article  PubMed  PubMed Central  Google Scholar 

  6. Greenberg JH, Zappitelli M, Devarajan P, Thiessen-Philbrook HR, Krawczeski C, Li S, Garg AX, Coca S, Parikh CR, TRIBE-AKI Consortium (2016) Kidney outcomes 5 years after pediatric cardiac surgery: the TRIBE-AKI study. JAMA Pediatr 170:1071–1078

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hessey E, Perreault S, Dorais M, Roy L, Zappitelli M (2019) Acute kidney injury in critically ill children and subsequent chronic kidney disease. Can J Kidney Health Dis 6:2054358119880188

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hessey E, Perreault S, Roy L, Dorais M, Samuel S, Phan V, Lafrance JP, Zappitelli M (2020) Acute kidney injury in critically ill children and 5-year hypertension. Pediatr Nephrol 35:1097–1107

    Article  PubMed  Google Scholar 

  9. Robinson CH, Jeyakumar N, Luo B, Wald R, Garg AX, Nash DM, McArthur E, Greenberg JH, Askenazi D, Mammen C, Thabane L, Goldstein S, Parekh RS, Zappitelli M, Chanchlani R (2021) Long-term kidney outcomes following dialysis-treated childhood acute kidney injury: a population-based cohort study. J Am Soc Nephrol 32:2005–2019

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kulvichit W, Kellum J, Srisawat N (2021) Biomarkers in acute kidney injury. Crit Care Clin 37:385–398

    Article  PubMed  Google Scholar 

  11. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238

    Article  CAS  PubMed  Google Scholar 

  12. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, NGAL Meta-analysis Investigator Group (2009) Accuracy of neutrophil gelatinase associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta analysis. Am J Kidney Dis 54:1012–1024

    Article  CAS  PubMed  Google Scholar 

  13. Mårtensson J, Bellomo R (2014) The rise and fall of NGAL in acute kidney injury. Blood Purif 37:304–310

    Article  PubMed  Google Scholar 

  14. Krzych ŁJ, Czempik PF (2019) Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials. Ann Intensive Care 9:85

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. **e CM, Yao YT, Yang K, Shen MQ, He LX, Dai Z, Evidence in Cardiovascular Anesthesia (EICA) Group (2022) Furosemide does not reduce the incidence of postoperative acute kidney injury in adult patients undergoing cardiac surgery: a PRISMA-compliant systematic review and meta-analysis. J Card Surg 37:4850–4860

    Article  PubMed  Google Scholar 

  16. Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG (2013) Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 17:R207

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lumlertgul N, Peerapornratana S, Trakarnvanich T, Pongsittisak W, Surasit K, Chuasuwan A, Tankee P, Tiranathanagul K, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Kellum JA, Srisawat N, FST Study Group (2018) Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care 22:101

    Article  PubMed  PubMed Central  Google Scholar 

  18. McMahon BA, Chawla LS (2021) The furosemide stress test: current use and future potential. Ren Fail 43:830–839

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138

    Google Scholar 

  20. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100

    Article  PubMed  Google Scholar 

  21. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

    Article  PubMed  PubMed Central  Google Scholar 

  22. Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F (2008) Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 396:49–55

    Article  CAS  PubMed  Google Scholar 

  23. Kashani K, Cheungpasitporn W, Ronco C (2017) Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med 55:1074–1089

    Article  CAS  PubMed  Google Scholar 

  24. Khorashadi M, Beunders R, Pickkers P, Legrand M (2020) Proenkephalin: a new biomarker for glomerular filtration rate and acute kidney injury. Nephron 144:655–661

    Article  CAS  PubMed  Google Scholar 

  25. Chen JJ, Chang CH, Huang YT, Kuo G (2020) Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis. Crit Care 24:202

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kakajiwala A, Kim JY, Hughes JZ, Costarino A, Ferguson J, Gaynor JW, Furth SL, Blinder JJ (2017) Lack of furosemide responsiveness predicts acute kidney injury in infants after cardiac surgery. Ann Thorac Surg 104:1388–1394

    Article  PubMed  Google Scholar 

  27. Borasino S, Wall KM, Crawford JH, Hock KM, Cleveland DC, Rahman F, Martin KD, Alten JA (2018) Furosemide response predicts acute kidney injury after cardiac surgery in infants and neonates. Pediatr Crit Care Med 19:310–317

    Article  PubMed  Google Scholar 

  28. Penk J, Gist KM, Wald EL, Kitzmiller L, Webb TN, Li Y, Cooper DS, Goldstein SL, Basu RK (2019) Furosemide response predicts acute kidney injury in children after cardiac surgery. J Thorac Cardiovasc Surg 157:2444–2451

    Article  CAS  PubMed  Google Scholar 

  29. Hasson DC, Zhang B, Krallman K, Rose JE, Kempton KM, Steele P, Devarajan P, Goldstein SL, Alder MN (2023) Acute kidney injury biomarker olfactomedin 4 predicts furosemide responsiveness. Pediatr Nephrol 38:3153–3161

    Article  PubMed  Google Scholar 

  30. McGalliard RJ, McWilliam SJ, Maguire S, Jones CA, Jennings RJ, Siner S, Newland P, Peak M, Chesters C, Jeffers G, Broughton C, McColl L, Lane S, Paulus S, Cunliffe NA, Baines P, Carrol ED (2020) Identifying critically ill children at high risk of acute kidney injury and renal replacement therapy. PLoS One 15:e0240360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kari JA, Shalaby MA, Sofyani K, Sanad AS, Ossra AF, Halabi RS, Aljuhani MH, Toffaha WM, Moria FA, Sabry S, Ahmed HA, Alhasan KA, Sharief S, Safdar O (2018) Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU. World J Pediatr 14:134–142

    Article  CAS  PubMed  Google Scholar 

  32. Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD, TRIBE-AKI Consortium (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22:1737–47

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hollinger A, Wittebole X, François B, Pickkers P, Antonelli M, Gayat E, Chousterman BG, Lascarrou JB, Dugernier T, Di Somma S, Struck J, Bergmann A, Beishuizen A, Constantin JM, Damoisel C, Deye N, Gaudry S, Huberlant V, Marx G, Mercier E, Oueslati H, Hartmann O, Sonneville R, Laterre PF, Mebazaa A, Legrand M (2018) Proenkephalin A 119–159 (Penkid) is an early biomarker of septic acute kidney injury: the kidney in sepsis and septic shock (Kid-SSS) study. Kidney Int Rep 3:1424–1433

    Article  PubMed  PubMed Central  Google Scholar 

  34. Jäntti T, Tarvasmäki T, Harjola VP, Pulkki K, Turkia H, Sabell T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, DiSomma S, Mebazaa A, Haapio M, Lassus J, Investigators CardShock (2021) Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock. Ann Intensive Care 11:25

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kieneker LM, Hartmann O, Bergmann A, de Boer RA, Gansevoort RT, Joosten MM, Struck J, Bakker SJL (2018) Proenkephalin and risk of develo** chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study. Biomarkers 23:474–482

    Article  CAS  PubMed  Google Scholar 

  36. Hartman SJF, Zwiers AJM, van de Water NEC, van Rosmalen J, Struck J, Schulte J, Hartmann O, Pickkers P, Beunders R, Tibboel D, Schreuder MF, de Wildt SN (2020) Proenkephalin as a new biomarker for pediatric acute kidney injury - reference values and performance in children under one year of age. Clin Chem Lab Med 58:1911–1919

    Article  CAS  PubMed  Google Scholar 

  37. Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL, Seneff MG, Chawla LS (2015) Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 26:2023–2031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Matsuura R, Komaru Y, Miyamoto Y, Yoshida T, Yoshimoto K, Isshiki R, Mayumi K, Yamashita T, Hamasaki Y, Nangaku M, Noiri E, Morimura N, Doi K (2018) Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels. Ann Intensive Care 8:8

    Article  PubMed  PubMed Central  Google Scholar 

  39. Goldstein SL, Krallman KA, Roy JP, Collins M, Chima RS, Basu RK, Chawla L, Fei L (2023) Real-time acute kidney injury risk stratification–biomarker directed fluid management improves outcomes in critically ill children and young adults. Kidney Int Rep 8:2690–2700

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SK, AS, JS, RL, AB, and PH managed the patients. SK participated in study protocol preparation, recruited patients, participated in data analysis, and drafted the first version of the manuscript. AS, AB, and PH conceptualized the study design, interpreted the data, and critically revised the manuscript. JS and RL assisted in protocol preparation, recruitment of patients, and drafting the manuscript. MT and LR helped in performing biomarkers for the study. All authors contributed to protocol preparation, drafting of the manuscript, and approved the final version of the manuscript. PH shall act as the corresponding author and guarantor of the paper.

Corresponding author

Correspondence to Pankaj Hari.

Ethics declarations

Consent to participate and publish the data

The authors affirm that human research participants provided informed consent to participate in the study and publish the data.

Ethics approval

The study was approved by the Institute Ethics Committee (IECPG-590/24.10.2019, RT-15/28.11.2019, titled “Furosemide stress test in predicting progression to AKI stage III in children admitted to the ICU with early stages of AKI”).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

graphical abstract (PPTX 82 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krishnasamy, S., Sinha, A., Lodha, R. et al. Furosemide stress test to predict acute kidney injury progression in critically ill children. Pediatr Nephrol (2024). https://doi.org/10.1007/s00467-024-06387-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00467-024-06387-5

Keywords

Navigation